Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer-Reference-Cited by-同舟云学术

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer

Published:2020-06-26 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Weykamp Fabian,König Laila,Seidensaal Katharina,Forster Tobias,Hoegen Philipp,Akbaba Sati,Mende Stephan,Welte Stefan E.,Deutsch Thomas M.,Schneeweiss Andreas,Debus Jürgen,Hörner-Rieber Juliane

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference51 articles.

1. Oligometastases;Weichselbaum;J Clin Oncol,1995

2. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas MD Anderson Cancer Center and assessment of prognostic factors;Hanrahan;Cancer Interdisc Int J Am Cancer Soc,2005

3. Radical radiation therapy for oligometastatic breast cancer: results of a prospective phase II trial;Trovo;Radiother Oncol,2018

4. Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: some patients survive longer than a decade;Milano;Radiother Oncol,2019

5. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy;Onal;Breast,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Radiotherapy in Oligoprogressive Breast Cancer;Journal of Personalized Medicine;2024-07-29

2. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer;Radiotherapy and Oncology;2024-07

3. Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience;Clinical Oncology;2024-06

4. Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions;Current Oncology Reports;2024-04-23

5. Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer;Frontiers in Endocrinology;2024-01-08